Nov 5, 2008

Oncolytics Biotech Inc. Announces U.S. Phase II Sarcoma Clinical Trial Conference Call

Nov 4, 2008

Oncolytics Biotech Inc. Announces 2008 Third Quarter Results

Nov 4, 2008

Oncolytics Biotech Inc. Announces Decision to Pursue Phase II/III Pivotal Clinical Trial

Nov 3, 2008

Oncolytics Biotech Inc. Announces Clinical Update Conference Call

Nov 3, 2008

Oncolytics Biotech Inc. Collaborators Present Positive Combination REOLYSIN(R) and Docetaxel Results at iSBTc Annual Meeting

Nov 3, 2008

Oncolytics Biotech Inc. Collaborators Present Positive Phase I/II Combination REOLYSIN(R) and Paclitaxel/Carboplatin Results at iSBTc Annual Meeting

Oct 23, 2008

Oncolytics Biotech Inc. Collaborators to Present Combination REOLYSIN(R) and Docetaxel Results at iSBTc Annual Meeting

Oct 23, 2008

Oncolytics Biotech Inc. Collaborators to Present Combination REOLYSIN(R) and Paclitaxel/Carboplatin Results at iSBTc Annual Meeting

Oct 23, 2008

Oncolytics Biotech Inc. Collaborators Present Reovirus and Melanoma Research at EORTC-NCI-AACR Symposium

Oct 22, 2008

Oncolytics Biotech Inc. Collaborators to Present Preclinical Combination REOLYSIN(R) and Cisplatin Research at EORTC-NCI-AACR Annual Meeting